Affiliation

Panda Palliative Care Team, Children’s National Medical Center, Washington

Corresponding Author

Elizabeth Bettini, PANDA Palliative Care Team, Children’s National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, Tel: 202-476-5000; E-mail: ebettini@childrensnational.org

Citation

Bettini, E., et al. Intranasal ketamine as analgesia to treat refractory pain in children in the outpatient setting. (2017) J Palliat Care Pediatr 2(1): 37- 39.

Copy rights

© 2017 Bettini, L. This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License.

Keywords

Abstract

  Ketamine has become a useful analgesic in treating neuropathies, disorders of central sensitization, and hyperalgesia in adults and children. It has been delivered by various routes including intravenous, oral, sublingual, topical, rectal, intramuscular, intrathecal, and intranasal with documented success in the inpatient and acute care settings. This article presents 3 cases in which intranasal ketamine was effectively used to treat refractory pain in children with various oncologic diagnoses that were home receiving palliative or hospice care.